CapsoVision, Inc

CV ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024
Revenue $13.6M $11.8M
Cost of Revenue $6.4M $5.4M
Gross Profit $7.2M $6.4M
Gross Margin 52.9% 54.2%
Operating Expenses
Research & Development $18.3M $15.1M
SG&A Expense $6.8M $4.2M
Operating Income $-25.5M $-19.9M
Operating Margin -188.3% -169.4%
Interest Expense
Pretax Income $-25.3M $-19.9M
Income Tax Expense $24.0K $11.0K
Net Income $-25.3M $-19.9M
Net Margin -186.8% -169.3%
EPS (Basic) $-1.03 $-0.82
EPS (Diluted) $-1.03 $-0.82
Shares Outstanding (Basic) 24.6M 24.2M
Shares Outstanding (Diluted) 24.6M 24.2M
Dividends Per Share